89 related articles for article (PubMed ID: 9477134)
1. Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlations.
Munker R; Younes A; Cabanillas F; Andreeff M
Leuk Lymphoma; 1997 Nov; 27(5-6):517-21. PubMed ID: 9477134
[TBL] [Abstract][Full Text] [Related]
2. Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromes.
Munker R; Midis G; Owen-Schaub L; Andreff M
Leukemia; 1996 Sep; 10(9):1531-3. PubMed ID: 8751476
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.
Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
[TBL] [Abstract][Full Text] [Related]
4. Soluble forms of CD95 and CD95 ligand after living related liver transplantation.
Seino K; Kayagaki N; Yamaguchi N; Takada Y; Uyama S; Kiuchi T; Tanaka K; Yagita H; Okumura K; Fukao K
Transplantation; 1999 Feb; 67(4):634-6. PubMed ID: 10071041
[TBL] [Abstract][Full Text] [Related]
5. Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma.
Hara T; Tsurumi H; Takemura M; Goto H; Yamada T; Sawada M; Takahashi T; Moriwaki H
Am J Hematol; 2000 Aug; 64(4):257-61. PubMed ID: 10911377
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary lesions and serum levels of soluble Fas (sCD95) in former hard coal miners.
Hoffmeyer F; Henry J; Borowitzki G; Merget R; Bünger J; Brüning T; Raulf-Heimsoth M
Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):60-3. PubMed ID: 21147622
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of TNF alpha and TNF receptor superfamily members in lymphoid neoplasia.
Metkar SS; Naresh KN; Manna PP; Srinivas V; Advani SH; Nadkarni JJ
Am J Hematol; 2000 Oct; 65(2):105-10. PubMed ID: 10996826
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers.
Christiansen I; Gidlof C; Kälkner K M; Hagberg H; Bennmarker H; Tötterman T
Br J Haematol; 1996 Mar; 92(3):639-46. PubMed ID: 8616029
[TBL] [Abstract][Full Text] [Related]
10. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
11. The Differences in the Levels of Oxidative Status Marker and Soluble CD95 in Patients with Moderate to Severe COPD during an Exacerbation and a Stable Period.
Soodaeva S; Kubysheva N; Klimanov I; Shutov A; Eliseeva T; Novikov V; Kontorshchikova K; Novikov D; Batyrshin I
Oxid Med Cell Longev; 2021; 2021():2105406. PubMed ID: 34925689
[TBL] [Abstract][Full Text] [Related]
12. Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina.
Ankersmit HJ; Weber T; Auer J; Roth G; Brunner M; Kvas E; Moser B; Spreitzer S; Lassnig E; Maurer E; Hartl P; Wolner E; Boltz-Nitulescu G; Eber B
Heart; 2004 Feb; 90(2):151-4. PubMed ID: 14729783
[TBL] [Abstract][Full Text] [Related]
13. Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation.
Wang YL; Zhang YY; Li G; Tang ZQ; Zhou YL; Zhu ZJ; Yao Z
World J Gastroenterol; 2005 Mar; 11(11):1700-4. PubMed ID: 15786554
[TBL] [Abstract][Full Text] [Related]
14. [The levels of soluble CD95 antigen and CD95+ mononuclear cells in patients with chronic obstructive lung diseases].
Kubysheva NI; Postnikova LB; Presniakova NB; Novikov VV
Klin Lab Diagn; 2009 Mar; (3):22-3. PubMed ID: 19391241
[TBL] [Abstract][Full Text] [Related]
15. CD95-mediated apoptosis and DNA fragmentation in MS.
Heesen C; Georghiu S; Gbadamosi J; Schoser BG
Acta Neurol Scand; 2000 Nov; 102(5):333-6. PubMed ID: 11083512
[TBL] [Abstract][Full Text] [Related]
16. Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients.
Kimura M; Tomita Y; Imai T; Saito T; Katagiri A; Tanikawa T; Takeda M; Takahashi K
Br J Cancer; 1999 Jul; 80(10):1648-51. PubMed ID: 10408413
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
[TBL] [Abstract][Full Text] [Related]
19. Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: higher concentrations in angioimmunoblastic T-cell lymphoma.
Yufu Y; Choi I; Hirase N; Tokoro A; Noguchi Y; Goto T; Uike N; Kozuru M
Am J Hematol; 1998 Aug; 58(4):334-6. PubMed ID: 9692400
[TBL] [Abstract][Full Text] [Related]
20. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
